Camber launches generic Mepron
Camber Pharmaceuticals is launching atovaquone oral solution. Atovaquone oral solution is the generic version of GlaxoSmithKline’s Mepron.
The product is used to treat or prevent pneumonia caused by a fungal infection called Pneumocystis carinii.
Camber’s generic is available in 750 mg/5 mL bottles.
No comments found